TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/6/21 17:02 | 1/4/21 | ZIOP | Ziopharm Oncology Inc | DE | Health | Drug | Pharmaceutical Preparations | Cooper Laurence James Neil | MA | DO | P,CEO | S | -286 | 2.71 | 0 | -106 | -6 | 1,799 | D | ||||||||||||||
12/31/19 16:37 | 12/27/19 | ZIOP | Ziopharm Oncology Inc | DE | Health | Drug | Pharmaceutical Preparations | Cooper Laurence James Neil | MA | DO | CEO | M.d | 100 | 2.24 | 0 | 45 | 3 | 1,733 | D | ||||||||||||||
12/31/19 16:37 | 12/30/19 | ZIOP | Ziopharm Oncology Inc | DE | Health | Drug | Pharmaceutical Preparations | Cooper Laurence James Neil | MA | DO | CEO | S.d | -540 | 4.88 | 0 | -111 | -6 | 1,733 | D | ||||||||||||||
11/9/17 16:43 | 11/8/17 | ZIOP | Ziopharm Oncology Inc | DE | Health | Drug | Pharmaceutical Preparations | Cooper Laurence James Neil | MA | O | CEO | P | 30 | 4.68 | 0 | 6 | 1 | 1,084 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |